TriSalus Life Sciences, Inc. (TLSI) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -28.21M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-28.21M | (m) |
| 2026-03-31 | (m) | $-27.31M | (m) |
| 2025-12-31 | (m) | $-39.23M | (m) |
| 2025-09-30 | (m) | $-39.58M | (m) |
| 2025-06-30 | (m) | $-31.17M | (m) |
| 2025-03-31 | (m) | $-27.21M | (m) |
| 2024-12-31 | (m) | $-30.05M | (m) |
| 2024-09-30 | (m) | $-55.25M | (m) |
| 2024-06-30 | (m) | $-54.35M | (m) |
| 2024-03-31 | (m) | $-63.99M | (m) |
| 2023-12-31 | (m) | $-59.04M | (m) |
| 2023-09-30 | (m) | $6.66M | (m) |
| 2023-06-30 | (m) | $-1.13M | (m) |
| 2023-03-31 | (m) | $2.25M | (m) |
| 2022-12-31 | (m) | $5.54M | (m) |
| 2022-09-30 | (m) | $8.78M | (m) |
| 2022-06-30 | (m) | $9.98M | (m) |
| 2022-03-31 | (m) | $7.98M | (m) |
| 2021-12-31 | (m) | $4.77M | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |